A phase II study of radiosurgery and temozolomide for patients with one to four brain metastases

被引：0
|
作者：
Fiveash, J. B.
Sawrie, S. M.
Guthrie, B. L.
Spencer, S. A.
Meredith, R. F.
Markert, J. M.
Nordal, R. A.
Conry, R. M.
Nabors, L. B.
机构：
[1] UAB, Wallace Tumor Inst, Birmingham, AL USA
[2] UAB, Birmingham, AL USA
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2007年 / 25卷 / 18期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
2048
引用
收藏
页数：1
相关论文
共 50 条
  • [21] A randomized phase II study of ipilimumab induction in patients with melanoma brain metastases receiving stereotactic radiosurgery.
    Silk, Ann W.
    Cao, Yue
    Gomez-Hassan, Diana
    Redman, Bruce G.
    Hayman, James
    Heth, Jason
    Lao, Christopher D.
    JOURNAL OF CLINICAL ONCOLOGY, 2015, 33 (15)
  • [22] Phase I study of ipilimumab with stereotactic radiosurgery for melanoma patients with brain metastases
    Shi, W.
    Wuthrick, E.
    Feeney, K.
    Werner-Wasik, M.
    Andrews, D. W.
    Evans, J. J.
    Judy, K.
    Farrell, C.
    Dicker, A. P.
    EUROPEAN JOURNAL OF CANCER, 2014, 50 : 49 - 49
  • [23] Phase II trial of sunitinib as maintenance therapy after stereotactic radiosurgery in patients with one to three newly diagnosed brain metastases
    Peereboom, D.
    Brewer, C.
    Suh, J. H.
    Chao, S. T.
    Rini, B. I.
    Parsons, M.
    Elson, P.
    Barnett, G.
    JOURNAL OF CLINICAL ONCOLOGY, 2010, 28 (15)
  • [24] A phase II trial combining nivolumab and stereotactic brain radiosurgery for treatment of brain metastases in patients with NSCLC.
    Wong, Philip
    Florescu, Marie
    Plourde, Marc-Emile
    Panet-Raymond, Valerie
    Pavic, Michel
    Owen, Scott Peter
    Masson-Cote, Laurence
    Menard, Cynthia
    Routy, Bertrand
    Tehfe, Mustapha
    Blais, Normand
    Roberge, David
    Masucci, Laura
    JOURNAL OF CLINICAL ONCOLOGY, 2021, 39 (15)
  • [25] Comparison of Stereotactic Radiosurgery and Whole Brain Radiotherapy in Patients with Four or More Brain Metastases
    Kim, Cheoljin
    Baek, Miyoung
    Park, Sungkwang
    Ahn, Kijung
    Cho, Heunglae
    RADIATION ONCOLOGY JOURNAL, 2009, 27 (03): : 163 - 168
  • [26] A Pilot/Phase II Study of Stereotactic Radiosurgery for Brain Metastases Using Rational Dose Selection
    Yu, J. B.
    Singh, C.
    Bindra, R. S.
    Contessa, J. N.
    Husain, Z. A.
    Hansen, J. E.
    Park, H. S. M.
    Roberts, K. B.
    Bond, J.
    Tien, C.
    Guo, F.
    Colaco, R. J.
    Housri, N.
    Magnuson, W. J.
    Omay, B.
    Chiang, V. L.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2018, 102 (03): : E372 - E373
  • [27] A Phase II Study of Neoadjuvant Stereotactic Radiosurgery for Large Brain Metastases: Clinical Trial Protocol
    Takami, Hirokazu
    Nassiri, Farshad
    Moraes, Fabio Y.
    Zadeh, Gelareh
    Bernstein, Mark
    Conrad, Tatiana
    Berlin, Alejandro
    Laperriere, Normand
    Millar, Barbara-Ann
    Shultz, David Benjamin
    Kongkham, Paul
    NEUROSURGERY, 2020, 87 (02) : 403 - 407
  • [28] Radiosurgery followed by planned observation in patients with one to three brain metastases
    Lutterbach, J
    Cyron, D
    Henne, K
    Ostertag, CB
    NEUROSURGERY, 2003, 52 (05) : 1066 - 1073
  • [29] Radiotherapy vs. temozolomide in the treatment of patients with lung cancer and brain metastases:: A nordic randomized phase II study.
    Wagenius, G.
    Brodin, O.
    Nyman, J.
    Greim, G.
    Hillerdal, G.
    Riska, H.
    Sundström, S.
    Grönberg, B.
    Wang, M.
    Garmo, H.
    JOURNAL OF CLINICAL ONCOLOGY, 2006, 24 (18) : 398S - 398S
  • [30] Phase II trial of temozolomide for leptomeningeal metastases in patients with solid tumors
    Perez Segura, Pedro
    Gil, Miguel
    Balana, Carmen
    Chacon, Ignacio
    Munoz Langa, Jose
    Martin, Maria
    Bruna, Jordi
    JOURNAL OF NEURO-ONCOLOGY, 2012, 109 (01) : 137 - 142
12345